Literature DB >> 27128171

Are there any additional mechanisms for haemolysis in HELLP syndrome?

L Sabau1, L Terriou2, F Provot3, F Fourrier4, C Roumier2, C Caron2, S Susen2, A S Ducloy-Bouthors1.   

Abstract

HELLP syndrome is a microangiopathy that leads to severe maternal complications. The objective of this study was to identify any additional mechanisms that could have contributed to HELLP syndrome-induced haemolysis. This is a pilot, prospective and observational study that lasted 9months. All patients with HELLP syndrome treated at academic tertiary care women hospital accepted to participate. Sixteen patients were included. In ten patients (63%), schizocytes were detected following a blood smear test. Six patients (38%) were diagnosed with a partial expression deficiency of proteins regulating the complement system (CD 55 or CD 59). In nine patients (56%), an activation of the complement classical pathway was detected. In two patients (13%), an ADAMTS 13 activity below 30% was detected. Three patients (19%) were diagnosed with a folate deficiency and one (6%) with an antiphospholipid syndrome. All patients developed maternal or fetal morbidity including nine (56%) an acute kidney injury. All patients but one had at least one additional mechanism that could contribute to haemolysis, besides a simple physical injury. Larger studies should be promoted to understand haemolysis in HELLP syndrome.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Complement system; HELLP syndrome; Haemolysis

Mesh:

Substances:

Year:  2016        PMID: 27128171     DOI: 10.1016/j.thromres.2016.03.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  The Complement Alternative Pathway and Preeclampsia.

Authors:  Layan Alrahmani; Maria Alice V Willrich
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

2.  Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.

Authors:  Cyril Mousseaux; Bérangère S Joly; Inna Mohamadou; Romain Arrestier; Alexandre Hertig; Cédric Rafat
Journal:  BMC Nephrol       Date:  2020-05-29       Impact factor: 2.388

Review 3.  Innate and Adaptive Immune Responses in HELLP Syndrome.

Authors:  Violeta Stojanovska; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

Review 4.  Molecular Advances in Preeclampsia and HELLP Syndrome.

Authors:  Angeliki Gardikioti; Theodora-Maria Venou; Eleni Gavriilaki; Evangelia Vetsiou; Ioulia Mavrikou; Konstantinos Dinas; Angelos Daniilidis; Efthymia Vlachaki
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.